Alnylam Pharmaceuticals, Inc.

Cambridge, Massachusetts, United States alnylam.com

Overview

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company pioneering the development of RNAi therapeutics. The company focuses on genetic-driven and rare diseases with a comprehensive pipeline leveraging their RNA interference platform.

Therapeutic areas

Genetic DiseasesCardiometabolic DiseasesRare Diseases

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832025-02-25

    Quality control unit review of records

  • 4832025-02-25

    Component written specification

  • 4832025-02-25

    Record maintenance 1 year (except exempt OTC)

Related companies

Bicycle Therapeutics plc
United Kingdom
ACHN Pharmaceuticals Inc.
USA
Advanced Biologics Corp
USA
Aegerion Pharmaceuticals, Inc.
United States
ALMB Pharmaceuticals, Inc.
USA
Amicus Therapeutics, Inc.
United States
Andelyn Biosciences, Inc.
United States
ANV Therapeutics Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo